Common oral opportunistic infections in Human Immunodeficiency Virus infection/Acquired Immunodeficiency Syndrome: Changing epidemiology; diagnostic criteria and methods; management protocols

2019 ◽  
Vol 80 (1) ◽  
pp. 177-188 ◽  
Author(s):  
Kannan Ranganathan ◽  
Krishna Mohan Rao Umadevi
Keyword(s):  
Human Immunodeficiency Virus ◽  
Virus Infection ◽  
Human Immunodeficiency Virus Infection ◽  
Diagnostic Criteria ◽  
Acquired Immunodeficiency Syndrome ◽  
Opportunistic Infections ◽  
Immunodeficiency Virus ◽  
Acquired Immunodeficiency ◽  
Immunodeficiency Syndrome

scholarly journals Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections.

1991 ◽  
Vol 1 (9) ◽  
pp. 1061-1080
Author(s):  
J S Berns ◽  
R M Cohen ◽  
R J Stumacher ◽  
M R Rudnick
Keyword(s):  
Human Immunodeficiency Virus ◽  
Virus Infection ◽  
Renal Insufficiency ◽  
Human Immunodeficiency Virus Infection ◽  
Acquired Immunodeficiency Syndrome ◽  
Opportunistic Infections ◽  
Immunodeficiency Virus ◽  
Nephrotoxic Drugs ◽  
Acquired Immunodeficiency ◽  
Immunodeficiency Syndrome

Patients with human immunodeficiency virus infection and the acquired immunodeficiency syndrome are often treated with a variety of potentially nephrotoxic drugs. This review summarizes the renal, fluid, and electrolyte complications of drugs used to treat human immunodeficiency virus and associated opportunistic infections. The pharmacokinetics of the drugs are also briefly reviewed, and dosing guidelines for the use of these drugs in patients who have renal insufficiency or who are receiving dialysis are provided.

Sign in / Sign up

Export Citation Format

Share Document